Bioziv Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 14.65%
- Profit Growth 26.67%
- Ebitda -50.80%
- Net Worth 25.70%
- Total Assets -2.46%
About Bioziv Healthcare
Bioziv Healthcare Private Limited (BHPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2017 (Seven years and 11 months 11 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajendra Singh and Shoaib Ahmad serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100CH2017PTC041435
- Company No.
041435
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Bioziv Healthcare Private Limited offer?
Bioziv Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Multivitamin Tablets & Capsules, Diclofenac, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Bioziv Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajendra Singh  | Director | 14-Mar-2017 | Current |
| Shoaib Ahmad | Director | 14-Mar-2017 | Current |
Financial Performance of Bioziv Healthcare.
Bioziv Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.65% increase. The company also saw a substantial improvement in profitability, with a 26.67% increase in profit. The company's net worth Soared by an impressive increase of 25.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioziv Healthcare?
In 2019, Bioziv Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioziv Healthcare?
Unlock and access historical data on people associated with Bioziv Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioziv Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioziv Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.